H. J. Senn – författare
Visar alla böcker från författaren H. J. Senn. Handla med fri frakt och snabb leverans.
12 produkter
Adjuvante zytostatische Chemotherapie
Zytostatische Therapie als Rezidivprophylaxe?
Av Heinz Huber, H. J. Senn m. fl.
Häftad, 1978
585 kr
Lägg i varukorg
Das Konzept der experimentellen Onkologie, schon im Stadium der Mikrometa- stasierung zytostatischer Medikamente einzusetzen, wird derzeit bei verschiede- nen menschlichen Tumoren auf breiter Basis untersucht. Damit hat die Frage nach den Erfolgsaussichten und der Indikationsstellung fur adjuvante …
Tumor Prevention and Genetics III
Av H.-J. Senn, R. Morant
Inbunden, 2004
2254 kr
Lägg i varukorg
Identification of cancer risk factors and potential prevention strategies have been some of the most important medical and research contributions to the improvement of public health in the past half-century (Steele 2003). Und- standing the role of lifestyle, exposure to endogenous factors and …
Cancer Prevention
Av Hans-Jorg Senn, H.-J. Senn m. fl.
Inbunden, 2007
2254 kr
Lägg i varukorg
This volume contains the main proceedings of the fourth international conference on "Cancer Prevention 2006," which was held during February 16–18, 2006, in St. Gallen, Switzerland. Written by international experts in the field, the book comprises a comprehensive update on the most recent …
Cancer Prevention
Av U. Kapp, H.-J. Senn
E-bok, 2007
2948 kr
Lägg i varukorg
This volume contains the main proceedings of the fourth international conference on "Cancer Prevention 2006," which was held during February 16–18, 2006, in St. Gallen, Switzerland. Written by international experts in the field, the book comprises a comprehensive update on the most recent …
Cancer Prevention
Av H.-J. Senn, U. Kapp
Häftad, 2010
2478 kr
Lägg i varukorg
This volume contains the main proceedings of the fourth international conference on "Cancer Prevention 2006," which was held during February 16–18, 2006, in St. Gallen, Switzerland. Written by international experts in the field, the book comprises a comprehensive update on the most recent …
Tumor Prevention and Genetics III
Av H.-J. Senn, R. Morant
Häftad, 2014
2474 kr
Lägg i varukorg
Identification of cancer risk factors and potential prevention strategies have been some of the most important medical and research contributions to the improvement of public health in the past half-century (Steele 2003). Und- standing the role of lifestyle, exposure to endogenous factors and …
Chemoprevention of Cancer
A Clinical Update
Av Craig Jordan, Alberto Costa m. fl.
E-bok, 2012
1502 kr
Lägg i varukorg
Pharmacologic interventions to prevent the evolution of human cancers are still in its infancy, although a good number o- mostly controlled - clinical studies have been performed in the past two decades. However, regarding the partially stagnating therapeutic results of major epithelial cancer …
Chemoprevention of Cancer
A Clinical Update
Av H.-J. Senn, Alberto Costa m. fl.
Häftad, 2011
1130 kr
Lägg i varukorg
Pharmacologic interventions to prevent the evolution of human cancers are still in its infancy, although a good number o- mostly controlled - clinical studies have been performed in the past two decades. However, regarding the partially stagnating therapeutic results of major epithelial cancer …
Adjuvante zytostatische Chemotherapie
Zytostatische Therapie als Rezidivprophylaxe?
Av M. Falkensammer, H. J. Senn m. fl.
E-bok, 2013
621 kr
Lägg i varukorg
Perioperative Chemotherapy
Rationale, Risk and Results
Av H.-J. Senn, F. Largiader m. fl.
E-bok, 2012
1470 kr
Lägg i varukorg
One reason for failure to cure solid tumors by surgery appears to be the impossibility of controlling metastases that are present but latent at the time of operation. This failure is a common clinical experience with aggressive neoplasms. but it is not always appreciated in tumors with longer …
Perioperative Chemotherapy
Rationale, Risk and Results
Av U. Metzger, F. Largiader m. fl.
Häftad, 2011
1130 kr
Lägg i varukorg
One reason for failure to cure solid tumors by surgery appears to be the impossibility of controlling metastases that are present but latent at the time of operation. This failure is a common clinical experience with aggressive neoplasms. but it is not always appreciated in tumors with longer …
